跳至主要内容
临床试验/NCT04753268
NCT04753268已完成不适用

Preliminary Examination of a Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors

Noom Inc.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年3月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Noom Inc.
入组人数
30
试验地点
1
主要终点
Program satisfaction

研究概览

简要总结

The purpose of this study is to evaluate the preliminary efficacy of a Noom Breast Cancer Weight Loss Program on weight loss outcomes, quality of life, and physical activity. Also, to qualitatively determine acceptability of this novel program among breast cancer survivors with overweight or obesity.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Able to understand and provide informed consent
  • 18 years and older
  • Overweight or obesity (BMI ≥ 27.5)
  • Not 6 months postpartum
  • Not planning to become pregnant in the next 7 months
  • Have a smartphone that is compatible with Noom's mobile app
  • Breast cancer survivor with stage I, II, or III
  • Completed active treatment (e.g, surgery, chemo, radiation, etc.) > 6 months ago

排除标准

  • Inability or unwillingness of a participant to give written informed consent
  • Currently pregnant or < 6 months postpartum
  • Plans to become pregnant within the next 7 months
  • Stage IV, metastatic cancer or DCIS
  • Currently taking insulin
  • Uncontrolled hypertension

结局指标

主要结局

Program satisfaction

时间窗: week 1 - 26 week

Satisfaction assessed via an in-house survey

Program engagement

时间窗: weeks 1-26

Engagement with the Noom program; measured as 1. Number of App opens 2. Messages to coach 3. Number of Steps 4. Logged food 5. Logged exercise 6. Group messages and likes 7. Articles read

Weight

时间窗: baseline to 6 months

Self-reported weight

Program retention

时间窗: weeks 1-26

i.e. % = (total participants - number of drop out) / Total number of participants) \* 100%

次要结局

未报告次要终点

研究者

发起方
Noom Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验